Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLC

CompletedOBSERVATIONAL
Enrollment

346

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

April 1, 2018

Study Completion Date

April 1, 2018

Conditions
Non Small Cell Lung Cancer Stage III
Trial Locations (22)

6020

Univ.-Klinik für Strahlentherapie-Radioonkologie, Innsbruck

10117

Department of Radiooncology, Charité Campus Mitte und Campus Virchow Berlin, Berlin

20246

Department of Radiooncology, Hamburg, Hamburg

23562

Department of Radiooncology Lübeck, Lübeck

24105

Department of Radiooncology, Kiel, Kiel

30625

Department of Radiooncology, Hannover, Hanover

40210

Department of Radiooncology, Duesseldorf, Düsseldorf

40225

Department of Radiooncology, Düsseldorf, Düsseldorf

48143

Department of Radiooncology, Muenster, Münster

50937

Department of Radiooncology Cologne, Cologne

68167

Department of Radiooncology, Mannheim, Mannheim

69120

Department of Radiooncology, Heidelberg, Heidelberg

81377

Department of Radiooncology, Munich (LMU, Campus Großhadern), Munich

93047

Department of Radiooncology, Regensburg, Regensburg

Unknown

Iridium Cancer Network, Antwerp

Department of Radiooncology, Erlangen, Erlangen

Department of Radiooncology, Munich (TUM), Munich

Department of Radiooncology, Sevilla, Seville

Klinik für Strahlentherapie, St. Gallen, Sankt Gallen

01307

Department of Radiooncology Dresden, Dresden

06120

Department of Radiooncology, Halle, Halle

07743

Department of Radiooncology, Jena, Jena

All Listed Sponsors
collaborator

Radiation Oncology Working Group of the German Cancer Society

OTHER

lead

Martin-Luther-Universität Halle-Wittenberg

OTHER

NCT03055715 - Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLC | Biotech Hunter | Biotech Hunter